Opendata, web and dolomites


A novel bone implant with enhanced bone healing capacity

Total Cost €


EC-Contrib. €






Project "CERAMENT-BC" data sheet

The following table provides information about the project.


Organization address
address: SCHEELEVAGEN 19
city: LUND
postcode: 223 63
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-09-01   to  2017-02-28


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BONE SUPPORT AB SE (LUND) coordinator 50˙000.00


 Project objective

The objective of the project is to bring the first bone implant with enhanced bone healing capacity to the market and clinical practice. The market demand for bone implants is steadily increasing driven by aging populations, increased demand for high quality of life and an increasing number of joint reconstruction surgeries. Enhancement of the bone healing process is often necessary, especially for patients with larger bone voids and gaps. The existing clinical methods targeting this need are based on the combination of Bone Graft Substitutes (BGS) with: • systemic treatment with Bone Active Drug (BAD), or • the off-label use of the BAD. Both alternatives create risks for side-effects and complications.

BONESUPPORT will move beyond the current state of the art and propose CERAMENT-BC – the first product combining a BGS with a BAD (bisphosphonate), enhancing the healing capacity of the implant. The commercial potential of this nano-modified material lies in the efficient local delivery of the drug to the targeted skeletal side, minimizing side-effects and improving quality of life for the patient.

The targeted users are orthopedic surgeons who need new methods for the enhancement of the bone healing process, reduction of secondary fractures and postoperative complications. CERAMENT-BC will meet those needs by combining the advantages of BGS and BAD and thus providing both fracture stability and a local therapeutic effect.

The Phase 1 study will develop a business plan for the commercialisation of the product. Assuring cost-efficient and innovative approaches to the treatment of musculoskeletal conditions is an EU-wide challenge. The project will address this challenge by proposing a new treatment option which for the first time combines an injectable biomaterial with a BAD.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CERAMENT-BC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CERAMENT-BC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)


Super Productive Line Printing Inkjet

Read More  

HelpingHAND (2018)

A 3D printed, affordable myoelectrical prosthetic hand of personalizeable size for optimal comfort and functionality

Read More  

HIL PT System (2017)

Revolutionary, cost effective, spatially efficient, proton therapy system for cancer treatment.

Read More